Literature DB >> 17060789

Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug.

Eric D Donnenfeld1, Ashley Donnenfeld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17060789     DOI： 10.1097/01.iio.0000212134.83513.11

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  10 in total

1.  Efficacy of systemic diclofenac sodium on intravitreal concentration.

Authors:  Yunes Panahi; Mostafa Naderi; Khosrow Jadidi; Hadise Hoseini; Mojtaba Abrishami
Journal:  Int Ophthalmol       Date:  2017-01-10       Impact factor: 2.031

2.  Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation.

Authors:  L David Waterbury; Danielle Galindo; Linda Villanueva; Cathy Nguyen; Milan Patel; Lisa Borbridge; Mayssa Attar; Rhett M Schiffman; David A Hollander
Journal:  J Ocul Pharmacol Ther       Date:  2011-02-25       Impact factor: 2.671

3.  Bromfenac-induced neurotrophic keratitis in a corneal graft.

Authors:  Nimmy Raj; Arnav Panigrahi; Mahboob Alam; Noopur Gupta
Journal:  BMJ Case Rep       Date:  2022-07-11

4.  Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution.

Authors:  Hyung Cho; Kenneth J Wolf; Eric J Wolf
Journal:  Clin Ophthalmol       Date:  2009-06-02

Review 5.  Bromfenac ophthalmic solution for the treatment of postoperative ocular pain and inflammation: safety, efficacy, and patient adherence.

Authors:  Rajesh K Rajpal; Bryan Ross; Sachin D Rajpal; Khoa Hoang
Journal:  Patient Prefer Adherence       Date:  2014-06-25       Impact factor: 2.711

6.  A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects.

Authors:  Kamran Hosseini; Thomas Walters; Robert DaVanzo; Richard L Lindstrom
Journal:  Clin Ophthalmol       Date:  2016-11-21

7.  Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 Study.

Authors:  William Trattler; Kamran Hosseini
Journal:  Ophthalmol Ther       Date:  2017-08-17

8.  Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction.

Authors:  Ester Carreño; Alejandro Portero; David J Galarreta; José M Herreras
Journal:  Clin Ophthalmol       Date:  2012-04-27

9.  The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.

Authors:  Ji Won Jung; Byung Hoon Chung; Eung Kweon Kim; Kyoung Yul Seo; Tae-im Kim
Journal:  Yonsei Med J       Date:  2015-11       Impact factor: 2.759

10.  The efficacy of bromfenac ophthalmic solution 0.07% dosed once daily in achieving zero-to-trace anterior chamber cell severity following cataract surgery.

Authors:  Steven M Silverstein; Mitchell A Jackson; Damien F Goldberg; Mauricio Muñoz
Journal:  Clin Ophthalmol       Date:  2014-05-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.